Buy Tirzepatide 2.5mg (R&D Only)
Tirzepatide 2.5mg is a high-purity research peptide formulated exclusively for scientific and laboratory applications. Designed as a dual receptor agonist, Tirzepatide simultaneously interacts with GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors, making it a valuable compound for advanced metabolic, endocrine, and receptor pharmacology research.
As one of the most recognised peptides in modern scientific research, Tirzepatide has generated substantial interest due to its unique receptor-targeting profile and broad research potential. Researchers continue to investigate its biological signalling characteristics, receptor interactions, and peptide pharmacology properties across multiple laboratory settings.
What Is Tirzepatide?
Tirzepatide is a synthetic peptide engineered to activate two key receptor systems involved in metabolic signalling and endocrine communication:
- GLP-1 Receptors
- GIP Receptors
This dual-agonist mechanism allows researchers to explore complex receptor interactions and biological signalling pathways within controlled laboratory environments.
Its innovative molecular structure has established Tirzepatide as one of the leading compounds in peptide science and metabolic research.
Key Features
High-Purity 2.5mg Formula
Each vial contains:
- 2.5mg Tirzepatide
- Research Grade Quality
- High-Purity Peptide Content
- Lyophilised Powder Format
Dual Receptor Agonist
Tirzepatide simultaneously targets:
- GLP-1 Receptors
- GIP Receptors
allowing researchers to investigate multiple receptor pathways using a single peptide compound.
Research Grade Manufacturing
Manufactured under strict quality-control standards to ensure consistency, purity, and laboratory reliability.
Suitable for Advanced Research
Commonly utilised in:
- Metabolic pathway studies
- Endocrine research
- Receptor pharmacology
- Peptide development
- Stability testing
- Formulation optimisation
Research Applications
Metabolic Research
Tirzepatide is frequently investigated in studies examining metabolic signalling pathways and receptor-mediated biological responses.
GLP-1 Receptor Studies
Researchers utilise Tirzepatide to evaluate receptor activation mechanisms and downstream signalling processes associated with GLP-1 pathways.
GIP Receptor Investigations
The peptide is commonly studied for its interaction with GIP receptors and related biological signalling systems.
Peptide Pharmacology
Suitable for studies involving:
- Receptor affinity analysis
- Biological activity evaluation
- Pharmacodynamic investigations
- Stability assessments
Endocrine Research
Researchers often utilise Tirzepatide in projects focused on endocrine signalling systems and receptor communication pathways.
Formulation Development
Applicable for:
- Delivery system evaluation
- Stability testing
- Compound optimisation
- Research product development
Why Choose Tirzepatide 2.5mg?
Advanced Dual Agonist Technology
Tirzepatide is regarded as one of the most important developments in contemporary peptide research.
Significant Scientific Interest
Its ability to activate both GLP-1 and GIP receptors has generated substantial attention across the scientific community.
Premium Research Quality
Produced according to rigorous standards to support reproducible laboratory outcomes and reliable research results.
Broad Scientific Applications
Suitable across multiple disciplines including:
- Metabolic biology
- Endocrinology
- Receptor science
- Peptide pharmacology
- Cellular signalling research
- Drug development investigations
Storage Information
For optimal stability:
- Store refrigerated at 2°C–8°C
- Protect from direct sunlight
- Avoid excessive heat exposure
- Keep vial tightly sealed
- Follow laboratory handling protocols
Proper storage helps preserve peptide integrity and maintain research quality.
Important Disclaimer
This product is supplied strictly for Research & Development purposes only. Not intended for human consumption, diagnosis, treatment, cure, or prevention of disease. All handling should be conducted by qualified professionals in controlled laboratory environments.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Tirzepatide 2.5mg |
| Active Ingredient | Tirzepatide |
| Strength | 2.5mg |
| Format | Lyophilised Powder |
| Category | Dual Agonist Research Peptide |
| Targets | GLP-1 & GIP Receptors |
| Grade | Research Grade |
| Storage | 2°C–8°C |
| Application | Research Use Only |
Frequently Asked Questions
What is Tirzepatide 2.5mg?
Tirzepatide 2.5mg is a research-grade dual agonist peptide developed for laboratory investigations involving GLP-1 and GIP receptor pathways.
Why is Tirzepatide considered a dual agonist?
Tirzepatide simultaneously activates GLP-1 and GIP receptors, allowing researchers to investigate multiple signalling pathways within a single compound.
What research areas commonly use Tirzepatide?
Researchers frequently utilise Tirzepatide in metabolic studies, endocrine research, receptor pharmacology, peptide science, and formulation development.
What format is Tirzepatide supplied in?
The product is supplied as a high-purity lyophilised peptide powder suitable for laboratory applications.
How should Tirzepatide be stored?
Store refrigerated between 2°C and 8°C while protecting the product from heat, moisture, and direct sunlight.
Is Tirzepatide intended for human use?
No. This product is supplied exclusively for research and development purposes.





Reviews
There are no reviews yet.